Curative effect of central venous catheter in interleukin-2-treated patients with hepatic hydrothorax
-
摘要: 目的观察中心静脉导管引流联合白细胞介素-2(IL-2)注射治疗肝性胸水的疗效。方法 40例肝性胸水患者随机分成治疗组(21例)和对照组(19例),两组患者均给予护肝、输白蛋白等支持治疗的基础上,对照组采用常规穿刺抽胸水治疗,治疗组则采用中心静脉导管留置胸腔引流管,完全排空胸水后,注入IL-2,观察两组患者的疗效及并发症情况。结果治疗组治疗总有效率为85.7%,对照组治疗总有效率为52.6%。两组比较差异有统计学意义(P<0.05);治疗组的胸水消退的天数、平均住院费用以及住院天数均明显缩短(P<0.05),并发症少。结论中心静脉导管联合IL-2治疗肝性胸水的疗效显著,值得临床推广。
-
关键词:
- 导管插入术,中心静脉 /
- 白细胞介素-2 /
- 胸水 /
- 肝硬化
Abstract: Objective To observe the curative effect of central venous catheter when combined with interleukin (IL) -2 treatment for hepatic hydrothorax. Methods Thirty-three patients with hepatic hydrothorax were randomly assigned to an experimental treatment group (n=17) or a control treatment group (n=16) .The experimental group received pleural effusion with continuous drainage by central venous catheter, while the control group was relieved of pleural effusion by conventional puncture.Both groups were administered IL-2 injection into the thoracic cavity after evacuation of pleural effusion.All patients were administered post-operative therapy, including albumin, to protect the liver.The curative effect and complications of two groups were observed. Results The central venous catheter group had a significantly better total effective rate than the conventional puncture control group (82.4% vs 56.3%;P<0.05) .The central venous catheter group also had significantly lower duration of pleural effusion persistence, average hospitalization expenses, and duration of hospital stay (P<0.05) , as well as experiencing fewer complications. Conclusion The central venous catheter method for IL-2 intrathoracic treatment produces a good therapeutic effect in patients with hepatic hydrothorax.-
Key words:
- catheterization /
- central venous /
- interleukin-2 /
- hydrothorax
-
[1]Barreales M, Sáenz-López S, lgarzabal A, et al.Refractoryhepatic hydrothorax:successful treatment with octreotide[J].Rev Esp Enferm Dig, 2005, 97 (11) :830-835. [2]McAdams HP, Goodman PC.Ambulatory selerothorapy formalignant pleural reflusions[J].Radiology, 1996, 199 (10) :133-135. [3]陈东风, 艾正琳.肝硬化腹水和肝性胸水的治疗[J].胃肠病学和肝病学杂志, 2009, 18 (4) :302-304. [4]李洪翠, 李肖, 唐承薇, 等.肝性胸水的诊治进展[J].中华肝脏病杂志, 2009, 17 (12) :958-960. [5] 张金凤.37例肝性胸水的临床诊治[J].中国实用医刊, 2009, 36 (12) :80-81. [6]Marchi E, Vargas FS, Acencio MM, et al.Talc and silver ni-trate induce systemic inflammatory effects during the acutephase of experimental pleurodesis in rabbits[J].Chest, 2004, 125 (6) :2268-2277. [7] 褚宏勋, 雷明盛.白介素-2对慢性乙肝患者外周树突状细胞的影响[J].中国医师杂志, 2008, 10 (8) :1066-1068. [8]黄晓霞, 段凤英.72例胸腔内注入顺铂联合白介素2治疗恶性胸腔积液疗效对比[J].国际呼吸杂志, 2009, 29 (11) :669-671. [9]周健, 刘黎.中心静脉导管联合高渗葡萄糖治疗肝性胸水的疗效观察[J].胃肠病学和肝病学杂志, 2011, 20 (8) :745-747.
本文二维码
计量
- 文章访问数: 2265
- HTML全文浏览量: 24
- PDF下载量: 632
- 被引次数: 0